Tissues are increasingly being analyzed at the single cell level in order to characterize cellular diversity and identify rare cell types. Single cell analysis efforts are greatly limited, however, by the need to first break down tissues into single cell suspensions. Current dissociation methods are inefficient, leaving a significant portion of the tissue as aggregates that are filtered away or left to confound results. Here, we present a simple and inexpensive microfluidic device that simultaneously filters large tissue fragments and dissociates smaller aggregates into single cells, thereby improving single cell yield and purity. The device incorporates two nylon mesh membranes with well-defined, micron-sized pores that operate on aggregates of different size scales. We also designed the device so that the first filtration could be performed under tangential flow to minimize clogging. Using cancer cell lines, we demonstrated that aggregates were effectively dissociated using high flow rates and pore sizes that were smaller than a single cell. However, pore sizes that were less than half the cell size caused significant damage. We then improved results by passing the sample through two filter devices in series, with single cell yield and purity predominantly determined by the pore size of the second membrane. Next, we optimized performance using minced and digested murine kidney tissue samples, and determined that the combination of 50 and 15 µm membranes was optimal. Finally, we integrated these two membranes into a single filter device and performed validation experiments using minced and digested murine kidney, liver, and mammary tumor tissue samples. The dual membrane microfluidic filter device increased single cell numbers by at least 3-fold for each tissue type, and in some cases by more than 10-fold. These results were obtained in minutes without affecting cell viability, and additional filtering would not be required prior to downstream applications. In future work, we will create complete tissue analysis platforms by integrating the dual membrane microfluidic filter device with additional upstream tissue processing technologies, as well as downstream operations such as cell sorting and detection.
Introduction
Complex tissues are increasingly being analyzed at the single cell level in an effort to catalogue diversity and identify rare driver cells. This would provide a comprehensive cell census that could be used to better understand tissue or organ biology, as promoted by the Human Cell Atlas initiative, 1-3 , as well as improve the diagnosis and treatment of major diseases including solid tumors. 4-10 Cell-based diagnostic methods such as flow cytometry, mass cytometry, and single cell RNA sequencing are ideally positioned to meet the above goals, [11] [12] [13] [14] but a major limitation is the need to first break tissue down into a suspension of single cells. 12 .
Traditionally, tissue has been dissociated by mincing into small pieces with a scalpel, digesting with proteolytic enzymes, mechanically dissociating with a pipetter and/or vortexing, and filtering with a cell strainer to remove remaining aggregates. Microfluidic technologies have recently been developed to automate and improve tissue dissociation, including on-chip digestion 15, 16 and disaggregation using sharp surface edges, post arrays, and branching channel networks that generate hydrodynamic fluid jets. [17] [18] [19] [20] While these devices have improved processing speed and single cell yield, small aggregates invariably remain after processing. Eliminating these aggregates by enhancing dissociation power or providing an on-chip separation mechanism would improve the quality of single cell suspensions and enable immediate downstream analysis.
Large tissue fragments and cell aggregates are commonly removed from digested tissue samples using cell strainers that contain nylon mesh filters with pore sizes ranging from 35-80 µm. These pores are large enough to allow small aggregates and clusters to pass through along with the single cells. While cell strainers with smaller pore sizes are available, they are typically not used due to concerns over the loss of single cells. Placing the filter membranes within a microfluidic device should alleviate this issue by minimizing hold-up volume and improving wash efficiency. Moreover, a microfluidic filter device that could be operated at high flow rate (>10 mL/min) could be directly integrated with previously developed hydrodynamic tissue digestion Page 4 of 36 Lab on a Chip and aggregate dissociation technologies. 16, 19, 20 Vacuum-driven filtration systems containing track-etched membranes, [21] [22] [23] and microfluidic devices containing microfabricated membranes, [24] [25] [26] [27] [28] have been described. These works primarily focused on size-based separation of single cells, typically larger circulating tumor cells (CTCs) from smaller blood cells. Pore sizes ranged from 5-10 µm to capture CTCs, and flow rates ranged from mL/hr for whole blood to 10 mL/min for diluted blood. In addition to size, cell deformability was shown to affect filtration, as cells could extrude through smaller pores depending on their viscosity and the flow rate. 23 Regarding cell aggregates, a novel microfabricated pillar array was designed to capture intact CTC clusters, 29 which have been correlated with higher metastatic potential and worse prognosis relative to individual CTCs. 30, 31 The CTC Cluster-Chip successfully trapped >90% of cancer cell line aggregates containing 5 or more cells when operated at 2.5 ml/h, but performance eroded quickly as aggregate size decreased and flow rate increased. This was superior to a track-etched membrane with 5 µm pores, presumably because cell clusters were able to squeeze through the pores. To date, the fate of single cells or cell clusters that pass through microporous membranes has not been investigated. Moreover, nylon membranes similar to those used in cell strainers have not been evaluated within a microfluidic device.
These nylon membranes are commercially available as single layer woven meshes with excellent pore density and uniformity down to 5 µm diameter.
In this work, we integrate nylon mesh membranes with pore sizes ranging from 5 to 50 µm into laser micro-machined, laminated plastic devices and investigate the filtration of tissue fragments, cell aggregates, and single cells. Devices are designed to operate under a traditional direct filtration mode, with sample passing through the membrane, or a tangential filtration mode that utilizes a cross-flow to prevent membrane clogging ( Fig. 1 ). Using cancer cell lines, we first show that nylon membranes with 10 µm pores or smaller remove all aggregates containing four or more cells, even when operated at high flow rates (mL/min). However, some clusters of 2 to 3 cells still pass through pores that are as small as 5 µm. Interestingly, we observe that single cell Page 5 of 36
Lab on a Chip numbers increase significantly after passing pore sizes that are smaller than the cells, by as much as five-fold, but this is also correlated with cell damage. We also show that dissociation is only weakly dependent on flow rate through the membrane, but is significantly diminished by the presence of a cross-flow under tangential filtration mode. We then enhance single cell recovery and purity by coupling two filter devices in series, such that aggregates are progressively dissociated into smaller sizes. Results predominantly correlate with the pore size of the second membrane, which is smaller and invariably used in direct filtration mode. Next, we optimize performance using minced and digested murine kidney tissue samples, and demonstrate that the combination of 50 and 15 µm pore size membranes produces the most single cells. Finally, we integrate the 50 and 15 µm pore size membranes into a single microfluidic device and validate results using murine kidney, liver, and mammary tumor tissue samples. After mincing and digesting with collagenase, the dual membrane filter device increases single cell yield by at least 3-fold, and in some cases by more than 10-fold, while also maintaining cell viability and reducing aggregates. Most strikingly, using the device after a brief 15 min digestion produces as many single cells as a 60 min digestion. Reducing processing time in this manner would help preserve cell viability, phenotype, and molecular signatures for subsequent molecular analysis.
Our simple and inexpensive microfluidic filter device significantly improves the recovery of single cells from tissue, and we envision future integration with upstream tissue processing technologies, such as our hydro-mincing and branching channel array, to maximize dissociation speed and efficiency.
Results and Discussion

Device Design
We designed our microfluidic filter device to remove tissue fragments and cell aggregates produced by standard enzymatic digestion procedures or comparable microfluidic processing. 16 This would enhance single cell purity for downstream diagnostic applications, and Page 6 of 36 Lab on a Chip any aggregates that were retained could be further processed to increase overall cell recovery.
A schematic of the device is shown in Fig. 1A . Sample is introduced via the inlet and comes into contact with a microporous membrane. Sample that passes through the membrane will exit through the effluent outlet. A portion of the sample can also be directed along the surface of the membrane and exit through the cross-flow outlet. This arrangement was chosen to maximize device utility by enabling operation in either direct and tangential filtration modes. Under direct filtration, all sample would pass through the membrane to maximize sample recovery and processing speed. Under tangential flow, the cross-flow would sweep larger tissue fragments and cell aggregates away from the membrane surface to prevent clogging. However, not all of the sample would be filtered, requiring multiple passes to collect the full sample.
Filter devices were fabricated using a commercial laminate approach, with channel features laser micro-machined into hard plastic (polyethylene terephthalate, PET). This provides a more robust end-product than alternative fabrication methods, such as photolithography and casting of polydimethyl siloxane (PDMS), and thus better supports the high flow rates and pressures that are desired for rapid tissue filtration. A total of seven PET layers were used, including two channel layers, three via layers, and two layers to seal the device ( Fig. 1B ). We included two locations for mounting thin, microporous membranes. The first location was in the center of the device, sandwiched between the middle channel and top via layers, and this membrane would be used for either tangential or direct filtration of large tissue fragments and cellular aggregates. We hypothesized that a second membrane with smaller pores could help maximize single cell purity. This membrane was placed immediately upstream of the effluent outlet, sandwiched between the bottom channel and second via layers, and would allow for direct filtration of smaller aggregates and clusters. Hose barbs were mounted in the top layer to serve as device inlets and outlets. After laser micro-machining, devices were assembled by stacking the various layers and membranes together, which were then firmly bonded using For the microporous membranes, we chose to utilize single-layer, woven nylon meshes similar to those used in cell strainers. These are commercially available with pore sizes down to 5 µm from numerous vendors as inexpensive, ready-to-use sheets that can be cut to size. The nylon threads create a lattice network with high pore density and uniformity, which should limit back-pressure and allow for high flow rates through the membrane. Micrographs of the nylon mesh membranes used in this study are shown in Fig. 1C , and properties are listed in Table 1 .
Moreover, we hypothesized that the narrow cross-section and rounded shape of the nylon threads will be ideal for dissociating aggregates into smaller clusters or even single cells. This is similar in principle to the sharp silicon edges of the Biogrid device, 17 but now operating on a large scale and, importantly, avoiding costly microfabrication. We would expect a dissociation mechanism to be most prevalent when aggregates are only slightly larger than the pores.
Aggregates that span many pores are more likely to be captured in a manner similar to traditional filtration. Track-etched membranes were considered, as they are also cheap, easy to use, and have been used extensively in single cell and aggregate filtration studies. [21] [22] [23] 29 However, the largest pore size available is 30 µm, and the random localization of the pores can cause them to overlap, particularly at high porosity. Microfabricated membranes offer precise control over pore size, shape, and location and have been used for cell filtration and compartmentalization. [24] [25] [26] [27] [28] 32 However, custom fabrication adds cost and complexity. Finally, pores within both track etched and microfabricated membranes are defects within the material, making them less durable at high porosity. For nylon mesh membranes, tensile forces will be resisted by the threads and dissipated throughout the material, making them more robust and failure-resistant. Thus, we concluded that nylon mesh membranes provided the optimal combination of cost and performance characteristics, while also providing potential for aggregate dissociation. A fabricated microfluidic filter device containing two nylon mesh membranes is shown in Fig. 1D .
Filtration of cell line aggregates
We first investigated single cell recovery and viability for nylon mesh membranes with 5, 10, 15, 25, or 50 µm pore sizes. To eliminate confounding effects, we fabricated devices containing only the first membrane (see Membrane 1 in Fig. 1A ). Experiments were performed using MCF-7 human breast cancer cells, which are strongly cohesive and provide large numbers of aggregates from standard tissue culture. We also note that MCF-7 cells are very large at ~20 µm diameter. Cell suspensions were passed through devices using a syringe pump, and initial tests were performed using direct filtration at 12.5 mL/min. Device effluents were recovered and imaged under phase contract microscopy to identify single cells, clusters of assay ( Fig. 2C ). Specifically, losses in viability scaled inversely with single cell recovery. As a result, the number of viable single cells that were recovered remained constant, around 40% higher than the control, for the 5, 10, and 15 µm pore sizes (see Supplementary Information, Fig. S1 ).
We next examined the effect of flow rate while still utilizing the direct filtration mode. We found that decreasing flow rate as low as 0.25 mL/min resulted in general trends toward lower single cell numbers and higher viability, but these changes were not significant ( Fig. 2D -E).
Aggregate, cluster, and single cell percentages were also similar for each flow rate (see Fig. S1 ). Finally, we investigated tangential filtration mode by diverting the sample between the cross-flow and effluent outlets using two syringe pumps that were operated in withdrawal mode. The total flow rate was held constant at 12.5 mL/min, similar to direct filtration experiments, while the cross-flow was varied from 40 to 80%. Afterwards, sample collected from the cross-flow outlet was passed through the membrane in direct filtration mode at 12.5 mL/min, and both effluents were combined prior to analysis. We found that single cell numbers were similar at all cross-flow ratios ( Fig. 2F ), which were significantly lower than direct filtration experiments at 12.5 mL/min (compare to Fig. 2B ). In fact, single cell numbers under tangential filtration were similar to direct filtration at 0.25 mL/min, even though all tangential experiments were performed utilized higher membrane flow-through rates (>2.5 mL/min). We did find that tangential filtration removed large aggregates more effectively at the 50 µm pore size (see Supplementary Information, Fig. S1 ). Taken together, we conclude that under pressure driven flow, aggregate and cluster dissociation depended primarily on membrane pore size and whether a cross-flow was present, and less so on the flow rate through the membrane.
Improving aggregate dissociation using two membranes
Based on these results, we postulated that aggregate dissociation could be enhanced by
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Therefore, we coupled two single-membrane filter devices in series using tubing and performed direct filtration experiments at 12.5 mL/min. Since we were primarily interested in dissociation, we initially tested the smaller pore size membranes in various combinations. We found that passing MCF-7 suspensions through two filter devices eliminated nearly all aggregates ( Fig.   3A ), even for the 15 µm pore size. Clusters were also reduced relative to the single filter experiments (compare to Fig. 2A ), reaching a low of 9% for the 5-5 membrane combination.
Single cell number and viability results are presented in Fig. 3B and C, respectively. Single cell yield did not change for the 5-5 and 10-5 membrane combinations relative to the single filter case (compare to Fig. 2B ), as samples were already well-dissociated. However, the 15-5 membrane combination produced fewer single cells, suggesting that the 15 µm membrane captured aggregates that the 5 µm membrane would have been able to dissociate into single cells. For the 10 µm membrane, single cell numbers were similar between single and double filter device experiments. The only case in which the use of two membranes was beneficial was for the 15-15 membrane combination, which increased single cell numbers increased from 50% to 150% higher than the control. We found that cell viability was predominantly determined by the pore size of the second, smaller membrane, and that values were similar to the single filter device experiments (compare to Fig. 2C ). While we again observed that viability was generally correlated with single cell numbers, live single cell numbers were lowest for conditions that employed the 5 µm membrane (see Supplementary Information, Fig. S2 ). Thus, we deemed the but now experiments were performed under tangential filtration. As with single filter device experiments, total flow rate was held constant at 12.5 mL/min and sample collected from the cross-flow outlet was passed through both devices under direct filtration mode. Using 60% cross-flow, we found that single cell, cluster, and aggregate populations were similar to the direct flow experiments utilizing the same 10 and 15 µm membranes ( Fig. 3D ). However, a small number of aggregates were recovered from the 50-15 membrane combination. Single cell recovery and viability results were also generally determined by the second, smaller membrane ( Fig. 3E and F ). As such, single cell numbers for the 10 µm pore size were similar to direct flow experiments using either one or two filter devices. For the 15 µm pore size, single cell numbers were similar to the 15-15 membrane combination under direct filtration, but now viability was significantly higher and equal to the control. It is unclear whether this change was related to using larger pore sizes in the upstream filter device, tangential filtration mode, or a combination of both. In total, live single cell numbers were ~2-fold greater than the control for all but the 25-15 combination (see Supplementary Information, Fig. S2 ). We note that nearly identical results were obtained for tangential filtration experiments performed using 80% cross-flow (see Supplementary Information, Fig. S2 ). Based on the combined results obtained with the MCF-7 cell aggregate model, we conclude that the second membrane predominantly dictated single cell recovery and viability because of its smaller pore size and consistent utilization of the direct filtration mode. Placing a second membrane upstream could improve results in some cases, particularly for the 15 µm membrane, but the pore size and operational mode of the first membrane was less important.
Optimization using murine kidney tissue
Since our ultimate goal is to use the filter devices with complex tissues, we next evaluated performance using murine kidney tissue samples. We continued to use two filter Page 12 of 36 Lab on a Chip devices in series, specifically the larger 25 or 50 µm pore sizes followed by smaller 10 or 15 µm pore sizes. The first filtration was performed under direct or tangential (60% cross-flow) mode, and a total flow rate of 12.5 mL/min. Fresh kidneys were harvested, sliced into histologically similar sections with a scalpel, minced into ~1 mm 3 pieces, and weighed. Samples were then digested with collagenase and mechanically treated by vortexing and pipetting, per routine protocol. We initially evaluated device performance using tissue samples that were only briefly digested with collagenase, as this would prove the most stringent test of membrane clogging and dissociation power. After digestion for 15 min, device treatment increased single cell numbers by at least 2-fold for all membrane combinations and filtration modes (Fig. 4A ).
Maximal results were ~4-fold higher than control, which were obtained for both 25 µm pore size combinations under direct filtration and both 50 µm pore size combinations under tangential filtration. Increasing digestion time to 30 min enhanced single cell recovery for all device conditions, which were now at least 5-fold higher than the control (Fig. 4B ). Results were generally greater for the 15 µm pore combinations regardless of the first membrane size or operational mode, which was consistent with our findings with the MCF-7 aggregate model. For both 15 and 30 min digestion times, we observed that large pieces of tissue were trapped by the first membrane ( Fig. 4A ), but membrane fouling was not an issue for either direct or tangential filtration modes, most likely because we were using relatively small tissue samples (<100 mg).
Based on these preliminary results, we chose to further evaluate cell suspensions using flow cytometry. Specifically, we used a panel of stains to assess cell viability and identify red blood cells and leukocytes, as we have previously described. 16, 20 We also chose to only use the 50 µm pore size in the first device due to higher porosity and the direct filtration mode since it was faster and easier to execute. The number of single tissue cells recovered per mg tissue is shown in Fig. 4C . Results at the 15 and 30 min digestion times were similar to the cell counter data in Figs. 4A and B , with both 50-10 and 50-15 membrane combinations producing 5-to 10fold more single cells than the control. Digesting for 60 min resulted in a dramatic increase in Page 13 of 36
Lab on a Chip single tissue cell numbers to ~20,000/mg. The 50-10 membrane combination was similar to the control, but the 50-15 membrane combination enhanced recovery by 2.5-fold. Notably, the 50-15 membrane combination also produced similar numbers of single tissue cells after digesting for 15 min as the control after digesting for 60 min. Cell viability was ~90% for all conditions at the 15 and 30 min digestion time points (Fig. 4D ). However, 60 min digestion decreased viability to ~80% for the control and ~75% for the 50-15 µm filter combination. We also used scattering information to quantify the percentage of aggregates relative to single cells (Fig. 4E ). We note that samples were passed through a 35 µm cell strainer prior to analysis to prevent clogging of the cytometer, and thus results likely only reflect cell clusters. Aggregate percentage increased progressively with digestion time for controls, from 3 to 11%, indicating that traditional dissociation methods are not effective at reducing tissue all the way down to single cells.
Aggregate percentages remained unchanged for the 50-15 membrane combination, but the 50-10 membrane combination reduced aggregates by approximately half at the 30 and 60 min digestion time points. Red blood cell and leukocyte recoveries are shown in the Supplementary Information (see Supplementary Information, Fig. S3 ), and closely mirrored the single tissue cell recovery results in Fig. 4C .
Filter device integration and validation using murine organ and tumor tissues
Based on the superior performance of the 50-15 membrane combination in terms of single tissue cells recovered from kidney samples, we fabricated a single device containing both membranes, as shown in Fig. 1 . The double membrane filter device was first validated using murine kidney samples that were digested for 60 min, and performance in terms of single tissue cell recovery and viability was comparable to the previous results obtained with two single filter devices coupled in series (see Supplementary Information, Fig. S3 ). We then tested freshly resected murine liver samples, which are generally easier to enzymatically digest, but hepatocytes are also well-known to be fragile. 16 After a brief 15 min digestion, approximately Page 14 of 36 Lab on a Chip 2500 single tissue cells were obtained per mg liver tissue for the control, and this was enhanced 5-fold by filter device treatment ( Fig. 5A) . At 30 min, single tissue cells increased by 2-fold for the control, but device treatment remained static, resulting in a more modest 2-fold improvement. Both control and device conditions were both much higher after 60 min digestion, around 40,000 single tissue cells/mg, indicating that the liver tissue had been fully broken down by enzymatic digestion. Viability remained greater than 90% for all conditions (Fig. 5B) , which was very encouraging considering the fragile nature of hepatocytes. Aggregates were present at ~1% for controls at all digestion times, and were generally reduced by device treatment although differences were not significant ( Fig. 5C ). As a final evaluation, we used mammary tumors that spontaneously arise in MMTV-PyMT transgenic mice. Tumors are generally considered among the most difficult epithelial tissues to dissociate due to their abnormal extracellular matrix composition. 33 For these tests, we modified the flow cytometry detection panel by adding an antibody specific for the general epithelial marker EpCAM. This enabled us to positively identify epithelial tissue cells, although this would include both normal or cancerous cells. Control conditions produced ~1000 single epithelial cells per mg tumor tissue at both the 15 and 30 min digestion time points, and this only increased to ~2000 cells/mg after 60 min digestion (Fig. 5D ). Device treatment enhanced single cell recovery by approximately 3-fold at all time points. Epithelial cell viability was only ~40-50% for all conditions (Fig. 5E ), potentially indicating that the tumor samples contained highly necrotic regions. A significant number of aggregates were present at all conditions, in the range of 15-20% of the total recovered population (Fig. 5F ). This suggests that more dissociation power will be needed to effectively liberate all cells from tumors. For both liver and tumor samples, red blood cell and leukocyte recoveries followed similar trends as the single liver tissue cell and single epithelial cell data (see Supplementary Information, Fig. S4 ).
Conclusions
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In this work, we have presented a simple and inexpensive microfluidic filter device that can rapidly and effectively improve the quality of single cell suspensions obtained from digested tissue samples. This was accomplished using nylon mesh membranes with well-defined, micron-scale pores that simultaneously filtered larger tissue fragments and dissociated smaller aggregates into single cells. Specifically, we demonstrated that using two nylon mesh membranes, first a larger pore size in the range of 25-50 µm followed by a smaller pore size in the range of 10-15 µm, resulted in dissociation of aggregates into progressively smaller sizes and ultimately enhanced single cell recovery. The dissociation effect was likely due to the combination of hydrodynamic shear forces and physical interaction with the nylon threads.
While this was effective, we note that care must be given to prevent cell damage, particularly for complex tissues that may contain cells of different sizes. Using the final dual membrane microfluidic filter device with 50 and 15 µm pore sizes, the number of single cells recovered from minced and digested murine kidney, liver, and tumor tissue samples was enhanced by at least 3-fold, and in some cases by more than 10-fold. We also showed that a brief 15 min digestion and filter device treatment could produce comparable single cell numbers to a full 60 min digestion. Importantly, cell viability was maintained for all tissue types and operating conditions, even fragile liver cells. These results will be important for advancing single cell analysis and atlasing of complex tissues, as dissociation has been a major bottleneck hindering these efforts. 12 Improved mechanical dissociation efficiency would help by reducing manual labor and enzyme cost, ensuring that sufficient sample is recovered even from smaller clinical specimens, and preventing bias in the final suspension towards cells that are easiest to isolate.
Alternatively, shorter digestion times would accelerate tissue processing work flows and could potentially better preserve the original phenotypic state from within the tissue. While we used nylon mesh membranes in this study, it is possible that track etched or microfabricated membranes with similar pore sizes could provide similar results. Our design also included the option to perform the first filtration under tangential mode, although this was not found to be Page 16 of 36 Lab on a Chip critical for generating single cells. We do note that it is possible that tangential filtration could become more important if tissue size were scaled up beyond 100 mg. Additionally, cell aggregates could be passed through the filter device continuously to increase single cell recovery, similar to diafiltration. 34 In future work, we will continue to optimize the microfluidic filter device using different tissue types. We will also integrate the filter device with our hydromincing digestion device to enable automated processing of cm-scale tissue samples, 16 as well as our branching channel dissociation device to maximize single cell numbers and purity. 19, 20 This integrated platform would be capable of processing full tissue samples all the way down to a highly pure suspension of single cells in a rapid and efficient manner. Furthermore, we will seek to integrate downstream technologies to enable on-chip sorting and analysis of single cells to create point-of-care diagnostic platforms for tissue samples.
Experimental
Device fabrication. Microfluidic devices were fabricated by ALine, Inc. (Rancho Dominguez, CA). Briefly, fluidic channels, vias, and openings for membranes and hose barb were etched into polyethylene terephthalate (PET) layers using a CO 2 laser. Nylon mesh membranes were purchased from Amazon Small Parts (10, 15, 25, and 50 µm pore sizes; Seattle, WA) or EMD Millipore (5 µm; Burlington, MA) as large sheets and were cut to size using the CO 2 laser.
Device layers, nylon mesh membranes, and hose barbs were then assembled, bonded using adhesive, and pressure laminated to form a single monolithic device. Quantifying cell aggregates by microscopy. Single cells and aggregates were assessed by microscopy using methods that we previously described. 20 Briefly, MCF-7 cell suspensions were imaged with a Hoffman phase contrast microscope and a 4x objective. Raw images were then converted to binary using MATLAB, and ImageJ was used to identify, outline, and calculate the area of all contiguous cellular units. Each unit was then classified based on area as a single cell (20 to 80 pixels 2 or 75 to 300 µm 2 ), cluster (80 to 200 pixels 2 or 300 to 750 µm 2 ), small aggregate (200 to 300 pixels 2 or 750 to 1120 µm 2 ), or large aggregate (>300 pixels 2 or >1120 µm 2 ). Referencing back to the micrographs, this corresponded to ~2 to 3 cells for clusters, ~4-10 cells for small aggregates, and >10 cells for large aggregates.
Flow cytometry. We closely followed the flow cytometry protocol that we previously developed for tissue suspensions. 16 Briefly, cell suspensions were co-stained with 2.5µg/mL anti-mouse CD45-PE monoclonal antibody (clone 30-F11, BioLegend, San Diego, CA) and 0.5X CellMask Green (Thermo Fisher, Waltham, MA) for 20 minutes at 37°C. Samples were then washed twice using PBS+ by centrifugation, co-stained with 5 µg/mL 7-AAD (BD Biosciences, San Jose, CA) and 12.5 µM DRAQ5 (BioLegend) on ice for at least 15 minutes, and analyzed on an Accuri C6 Flow Cytometer (BD Biosciences). Flow cytometry data was compensated and analyzed using FlowJo software (FlowJo, Ashland, OR), and a sequential gating scheme was used to identify 
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